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Introduction
Macrophages are important imaging targets for identify-
ing and monitoring high-risk atherosclerotic plaque.
Human heavy chain ferritin (HFn) is a promising nanos-
cale protein cage platform for cellular and molecular
imaging, demonstrating substantial in vitro uptake by
macrophages.
Purpose
To evaluate the in vivo uptake and distribution of MRI
and fluorescent HFn nanoparticles in mouse atherosclero-
sis.
Methods
A macrophage-rich carotid lesion in FVB mice (n = 12)
was induced as follows: high fat diet for 4 weeks then dia-
betes induction by 5 daily intraperitoneal injections of
streptozotocin. Two weeks later, we performed carotid
ligation of the left common carotid artery. In the first
group of mice (n = 5), an MRI form of HFn containing
iron oxide (HFn-3000Fe) was injected via tail vein (25
mgFe/kg) 2 weeks after carotid ligation. Mice were sacri-
ficed 48 hours after injection and HFn-Fe uptake was
assessed histologically by Perl's iron staining. In the sec-
ond group of mice (4 diseased and 3 sham), HFn was
labeled with the near-infrared (NIR) fluorophore Cy5.5
(HFn-Cy5.5: 4.6 Cy5.5 dye/cage) and injected via tail vein
(8 nmol of Cy5.5) 2 weeks after carotid ligation. Mice
were imaged serially by in vivo NIR imaging up to 48
hours. At 48 hours, both carotid arteries were exposed for
in situ NIR imaging, and then removed for ex vivo NIR
imaging. All mice were imaged under 2% isoflurane
anesthesia using the MaestroTM in-vivo imaging system
(CRI, Woburn, MA). After the NIR imaging, both carotid
arteries were removed and cut into 2 mm sections for con-
focal fluorescence microscopy to detect HFn-Cy5.5 colo-
calized with macrophages.
Results
HFn iron oxide nanoparticles (HFn-Fe) were taken up by
macrophages in the ligated left carotid artery at 48 hours,
as demonstrated by histology (Fig 1A). No HFn-Fe uptake
was seen in the control right carotid arteries. In vivo fluo-
rescence imaging detected HFn-Cy5.5 at 10 min after
intravenous injection, with the predominant signal in the
liver, bladder, and neck lymph nodes. In situ (Fig 2A), the
average fluorescence signal was significantly higher in the
ligated left carotid arteries at 48 hours (Left: 0.27 ± 0.05,
Right: 0.13 ± 0.04, p = 0.04). No significant signal was
seen in sham-operated mice (Left: 0.16 ± 0.06, Right: 0.12
± 0.01, p = 0.3). The enhanced signal in the ligated left
carotid arteries was further confirmed by ex vivo fluores-
cence imaging (Left: 429 ± 23, Right: 10 ± 10, p = 0.0001),
with minimum signal detected in the sham-operated mice
(Left: 12 ± 12, Right: 0 ± 0, p = 0.4) (Fig 2B). On confocal
fluorescence microscopy, HFn-Cy5.5 nanoparticles colo-
calized with macrophages in the neointima of the ligated
carotid artery (Figure 1B).
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Human ferritin protein cages labeled with iron oxide or
fluorophore localize to macrophages in the atheroscle-
rotic lesions in vivo. These initial results encourage further
investigation into the use of protein cage architectures as
a novel platform for MR or NIR contrast agents for detect-
ing macrophage infiltration within atherosclerotic
plaques.
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